Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions.
Vart P, Correa-Rotter R, Hou FF, Jongs N, Chertow GM, Langkilde AM, McMurray JJV, Rossing P, Sjöström CD, Stefansson BV, Toto RD, Douthat W, Escudero E, Isidto R, Khullar D, Bajaj HS, Wheeler DC, Heerspink HJL.
Vart P, et al. Among authors: stefansson bv.
Kidney Int Rep. 2022 Feb 2;7(4):699-707. doi: 10.1016/j.ekir.2022.01.1060. eCollection 2022 Apr.
Kidney Int Rep. 2022.
PMID: 35497805
Free PMC article.